- Home
- WGSWW vs NEP Comparison
WGSWW vs NEP Comparison
Compare WGSWW & NEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- NEP
- Stock Information
- Founded
- WGSWW N/A
- NEP 2014
- Country
- WGSWW United States
- NEP United States
- Employees
- WGSWW 1000
- NEP N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- NEP Electric Utilities: Central
- Sector
- WGSWW Technology
- NEP Utilities
- Exchange
- WGSWW Nasdaq
- NEP Nasdaq
- Market Cap
- WGSWW N/A
- NEP N/A
- IPO Year
- WGSWW 2020
- NEP N/A
- Fundamental
- Price
- WGSWW $0.19
- NEP $16.44
- Analyst Decision
- WGSWW
- NEP Hold
- Analyst Count
- WGSWW 0
- NEP 17
- Target Price
- WGSWW N/A
- NEP $25.14
- AVG Volume (30 Days)
- WGSWW N/A
- NEP 3.4M
- Earning Date
- WGSWW N/A
- NEP 10-23-2024
- Dividend Yield
- WGSWW N/A
- NEP 22.35%
- EPS Growth
- WGSWW N/A
- NEP 60.87
- EPS
- WGSWW N/A
- NEP 2.17
- Revenue
- WGSWW N/A
- NEP $1,167,000,000.00
- Revenue This Year
- WGSWW N/A
- NEP $20.50
- Revenue Next Year
- WGSWW N/A
- NEP $3.77
- P/E Ratio
- WGSWW N/A
- NEP $7.57
- Revenue Growth
- WGSWW N/A
- NEP 33.98
- 52 Week Low
- WGSWW N/A
- NEP $15.55
- 52 Week High
- WGSWW N/A
- NEP $35.15
- Technical
- Relative Strength Index (RSI)
- WGSWW N/A
- NEP 27.10
- Support Level
- WGSWW N/A
- NEP $15.55
- Resistance Level
- WGSWW N/A
- NEP $17.38
- Average True Range (ATR)
- WGSWW 0.00
- NEP 0.82
- MACD
- WGSWW 0.00
- NEP -0.17
- Stochastic Oscillator
- WGSWW 0.00
- NEP 16.89
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.